Totipotent nuclease

Nanjing Cellnuo Biopharmaceutical Co., Ltd., established in 2020, manufactures prophylactic biological products, enzymes, proteins/antigens/polypeptides, animal extracts, and specialized reagents, alongside drug development technology services. The company emphasizes customized service with flexible product quality, packaging, and payment arrangements, and — backed by international approvals, an experienced R&D staff, and a large product line — offers CMO contract manufacturing while accommodating buyer specifications and small orders, distributing across Central/South America, Eastern Europe, Asia, the Middle East, Western Europe, Australasia, Africa, and North America.